about
High serum YKL-40 level after surgery for colorectal carcinoma is related to short survivalExpression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitisDetection of fetal-specific DNA after enrichment for trophoblasts using the monoclonal antibody LK26 in model systems but failure to demonstrate fetal DNA in maternal peripheral blood.The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.Gene expression profiling of placentas affected by pre-eclampsiaThe role of anti-Müllerian hormone in female fertility and infertility - an overview.Biochemical evaluation of endometrial function at the time of implantation.Pregnancy-specific beta 1-glycoprotein (SP1) in serum and tissue from patients with benign and malignant breast tumours.Serum YKL-40 and colorectal cancer.Are there characteristics of the false-negative cases from the first trimester combined screening programme for Down syndrome?Recent progress in the utility of anti-Müllerian hormone in female infertility.Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.Discordant non-invasive prenatal testing (NIPT) - a systematic review.Pregnancy-"specific" beta 1-glycoprotein (SP1): purification, characterization, quantification and clinical application in malignancies (a review).Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.zeta-, epsilon-, and gamma-Globin mRNA in blood samples and CD71(+) cell fractions from fetuses and from pregnant and nonpregnant women, with special attention to identification of fetal erythroblasts.Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.Prenatal characteristics of false negative cases from first-trimester screening of Down syndrome (trisomy 21).Mining of hospital laboratory information systems: a model study defining age- and gender-specific reference intervals and trajectories for plasma creatinine in a pediatric population.Preanalytical handling of samples for measurement of plasma lactate in HIV patients.Anti-Müllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility.Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.The antiprogesterone Org 31710 inhibits human blastocyst-endometrial interactions in vitro.Glycodelin in endometrial flushing fluid and endometrial biopsies from infertile and fertile women.First trimester PAPP-A2, PAPP-A and hCGβ in small-for-gestational-age pregnancies.Investigation on the ability of first trimester glycodelin and angiopoietin-2 to predict small-for-gestational age pregnancies at delivery.Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth.Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer.Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy.Affinity purification of native glycodelin from amniotic fluid for biological investigations and development of a glycodelin ELISA for clinical studies.Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast.Differential increase in the maternal serum concentrations of the placental proteins human chorionic gonadotrophin, pregnancy-specific beta 1-glycoprotein, human placental lactogen and pregnancy-associated plasma protein-A during the first half of nMaternal serum laeverin (aminopeptidase Q) measured in the first trimester of pregnancy does not predict preeclampsia.Purification of the major component of the pregnancy-specific beta 1-glycoprotein (SP1) by affinity chromatography, and application to a highly sensitive radioimmunoassay.First trimester D-vitamin in nulliparous women with early and late pre-eclampsia.Effect of syncytiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells.Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onsetProspective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCGFirst-Trimester Risk Calculation for Trisomy 13, 18, and 21: Comparison of the Screening Efficiency between 2 Locally Developed Programs and Commercial SoftwareA randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery
P50
Q28215091-C6C8993C-DA12-4D68-9612-D5EE9B84DC00Q28346266-A1CAAB21-278C-488A-96A9-66A1F8730851Q30671600-8899C7F2-0D18-4369-ABEA-3755BD0549F7Q31089104-63B98F89-EB37-4300-969D-CCA49221902EQ33700903-921DCAFE-1915-4201-8C2B-00D9E5D6CB7DQ34278051-18B29221-4CBE-444A-8F52-2C994E1AFFC7Q34758858-692229B7-5C9D-4D93-A553-0FD05A5D22CBQ35991393-7390D9D1-6999-4636-8AE8-FEA428ED8A1FQ36619099-DB85B6FF-36E7-43AF-B533-E23B9071EC21Q38194834-6CDE2C19-9A20-41F2-BE68-ADF57BF0BE74Q38203771-A0131B75-7539-461B-998D-A14A4EA65BCDQ38291465-DAC6AB23-6578-4A29-90CD-47376CA5A3B8Q39223783-38D94DFC-0797-4848-B2FD-519FAED58233Q40080920-9E99BD7F-007D-4A95-B605-23CDBE8C2568Q40610463-3EC709B7-7064-4FB4-90A6-9F48D1DA9453Q40818089-CB682C26-DAEB-4FED-ADB7-04DF248F7865Q43577164-FBF5B26C-099C-4EE5-8919-AD7FE61E32BFQ43930683-36345882-B200-43D8-8848-86A54CB94DF3Q44585653-D26FF93E-CA75-4C66-A2FC-5A7B122280B5Q44640087-7E308F50-1EF0-469E-A1EC-56402A89447CQ44745798-A65E7D41-1A84-4B56-A56A-E9D7FAE60F3CQ45221453-2B8F3C22-EBAE-4A92-9702-0BA73087A21CQ46438541-69D336EB-A108-4DFE-BA04-2DA0B4B3C65FQ47255802-FDCD9B16-845B-4315-9EE4-D679B93E3304Q48108034-FB9EA1AA-F0E2-4AE7-B87F-DA6B10D83960Q48229116-70295525-0AFA-4A86-ABE2-FA8BD40B9230Q48624425-2EAE56BC-D07F-49E1-95BA-18C022FDC009Q51032719-C2EAB03D-2608-4FEE-BA8E-F3AC3CA1594AQ51047740-4212105B-120B-473A-A1B6-61E0E5668EF1Q51422203-F1781727-96D8-4A8B-AAD5-BF92FE534CB9Q52189130-7DBAC4A4-F973-4D68-93F7-D23A1745E853Q52352596-D61377B4-C271-4FF9-A276-263A4715A05BQ52571842-8FC94DDA-48B8-4B47-8F2A-F80F5169A682Q53435448-B5193BDF-DEFF-46C6-8F77-FD557072DC91Q54398066-62B923AA-C961-452F-814F-FC10C6CE2317Q54574981-6CEB9A2E-2DDE-4E17-A3DE-5763B00D35E6Q57420739-D4FDD13C-8E58-4568-A7AD-6A6CC7094B0BQ57917827-441FDA85-4D74-440E-9410-DAA4A46BDF70Q59694000-29C72BAA-C125-449A-96A7-909CF1C5AFBBQ63753444-03A23AEF-ED0A-4E4C-9696-B9693368C50D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Steen Sørensen
@ast
Steen Sørensen
@en
Steen Sørensen
@es
Steen Sørensen
@nl
type
label
Steen Sørensen
@ast
Steen Sørensen
@en
Steen Sørensen
@es
Steen Sørensen
@nl
prefLabel
Steen Sørensen
@ast
Steen Sørensen
@en
Steen Sørensen
@es
Steen Sørensen
@nl
P106
P1153
16640194600
P31
P496
0000-0002-9766-5820